Quidelortho Corp
F:QL1A

Watchlist Manager
Quidelortho Corp Logo
Quidelortho Corp
F:QL1A
Watchlist
Price: 25 EUR -10.07% Market Closed
Market Cap: 1.7B EUR

Net Margin

-50.8%
Current
Declining
by 21.7%
vs 3-y average of -29.1%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-50.8%
=
Net Income
$-1.2B
/
Revenue
$2.7B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-50.8%
=
Net Income
€-1.2B
/
Revenue
$2.7B

Peer Comparison

Country Company Market Cap Net
Margin
US
Quidelortho Corp
F:QL1A
1.9B EUR
Loading...
US
Abbott Laboratories
NYSE:ABT
191.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
190.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
138.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
137.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
130.7B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
59B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.4B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.2B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49.6B USD
Loading...
US
Resmed Inc
NYSE:RMD
38B USD
Loading...

Market Distribution

Lower than 81% of companies in the United States of America
Percentile
19th
Based on 15 072 companies
19th percentile
-50.8%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Quidelortho Corp
Glance View

Market Cap
1.7B EUR
Industry
Health Care

QuidelOrtho Corporation has emerged as a significant player in the realm of diagnostic healthcare, formed through the strategic merger of Quidel Corporation and Ortho Clinical Diagnostics. This union brought together Quidel's expertise in rapid diagnostic testing solutions and Ortho Clinical's strengths in in vitro diagnostics, aiming to create a powerhouse capable of addressing the evolving needs of modern healthcare systems globally. Quidel, originally known for its swift point-of-care diagnostic tools for infectious and other diseases, found a strategic complement in Ortho Clinical's laboratory-based testing and transfusion medicine capabilities. This merger allowed QuidelOrtho to leverage both companies’ technological innovations and established customer bases, effectively broadening their market reach and ensuring a diversified revenue stream. The company operates by developing, manufacturing, and marketing a comprehensive range of diagnostic solutions that serve both healthcare professionals and patients alike. At the heart of QuidelOrtho's operations is its commitment to enhancing patient outcomes through precision testing—a focus that aligns with the growing demand for accurate and reliable diagnostic information. Revenue generation stems from its extensive portfolio, which includes point-of-care testing kits, laboratory instruments, and other diagnostic equipment. By providing indispensable tools that aid in the early detection and management of diseases, QuidelOrtho not only supports healthcare providers in improving clinical outcomes but also positions itself as a crucial contributor to the global medical landscape. Its varied product lines and strategic innovations continue to reinforce its role in promoting public health and advancing medical diagnostics.

QL1A Intrinsic Value
74.81 EUR
Undervaluation 67%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-50.8%
=
Net Income
$-1.2B
/
Revenue
$2.7B
What is Quidelortho Corp's current Net Margin?

The current Net Margin for Quidelortho Corp is -50.8%, which is below its 3-year median of -29.1%.

How has Net Margin changed over time?

Over the last 3 years, Quidelortho Corp’s Net Margin has decreased from 26.1% to -50.8%. During this period, it reached a low of -76.9% on Dec 29, 2024 and a high of 26.1% on Sep 2, 2022.

Back to Top